Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin.

Medical oncology (Northwood, London, England) - 1 Dec 2011

Berstein Lev M, Boyarkina Marina P, Tsyrlina Evgenia V, Turkevich Elena A, Semiglazov Vladimir F

Abstract excerpt

The coexistence of type 2 diabetes with breast cancer may result in poorer cancer-related survival due to a number of mediating factors including an alteration of tumor tissue hormonal sensitivity. Previous studies have shown that receptor status of breast tumors in diabetics may be changed; however, the mode of therapy for diabetes was usually ignored. This work presents the results of an analysis of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Immunohistochemistry

Share to Insulin

Share to Metformin

Share to Receptors, Progesterone

Share to Sulfonylurea Compounds

Source

Identifiers

PMID: 20490716
DOI: 10.1007/s12032-010-9572-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin.PMID 20490716Read ↗

[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives].Semantic proximity Read ↗

Metformin may improve the outcome of patients with breast cancer and type 2 diabetes mellitus through the effect of tumor immune microenvironment.Semantic proximity Read ↗

Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.Semantic proximity Read ↗

Estrogen and progesterone receptor expression in the mammary gland tumors.Semantic proximity Read ↗

Comparative G-Protein-Coupled Estrogen Receptor (GPER) Systems in Diabetic and Cancer Conditions: A ReviewSemantic proximity Read ↗

In-Silico Study of the Immune Systems Associated Genes in Case of Type-2 Diabetes with Insulin Action and Resistance and in ObesitySemantic proximity Read ↗

Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.Semantic proximity Read ↗

The loss of progesterone receptor predicts more aggressive biological features and worse outcomes in estrogen receptor-positive and HER2-negative inflammatory breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.